Cargando…
Time to invest in tuberculosis research and disease control
Autor principal: | The Lancet Respiratory Medicine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036129/ https://www.ncbi.nlm.nih.gov/pubmed/36966796 http://dx.doi.org/10.1016/S2213-2600(23)00102-9 |
Ejemplares similares
-
Tackling tuberculosis: what lies beneath the surface?
por: The Lancet Respiratory Medicine
Publicado: (2022) -
COVID-19 pathophysiology: looking beyond acute disease
por: The Lancet Respiratory Medicine
Publicado: (2021) -
COVID-19 heralds a new era for chronic diseases in primary care
por: The Lancet Respiratory Medicine
Publicado: (2020) -
COVID-19 testing in the UK
por: The Lancet Respiratory Medicine
Publicado: (2020) -
The future of critical care: lessons from the COVID-19 crisis
por: The Lancet Respiratory Medicine
Publicado: (2020)